News Archives

• April 30, 2012

• Horizon Discovery and H3 Biomedicine collaborate to identify and validate novel cancer targets

•  
• Read Story

• April 23, 2012

• Horizon Discovery receives the Queen’s Award for Enterprise in International Trade

•  
• Read Story

• March 26, 2012

• Horizon Partners with EMQN to Minimise Variability in Cancer Diagnostic Testing Across Europe

•  
• Read Story

• March 21, 2012

• Horizon Discovery Named Business of the Year

•  
• Read Story

• March 12, 2012

• Horizon Discovery & Rosalind Franklin University to Develop Cystic Fibrosis Cellular Disease Models

•  
• Read Story

• March 06, 2012

• Horizon Discovery launches rAAV-mediated genome editing support website

•  
• Read Story

• February 16, 2012

• Horizon Discovery Joins 4D Cell Fate Consortium

•  
• Read Story

• January 31, 2012

• Horizon and UK NEQAS ICC Announce Partnership to Improve Accuracy of Lung Cancer Diagnostic Testing

•  
• Read Story

• January 23, 2012

• Horizon Discovery Appoints Eric Rhodes as Chief Technical Officer

•  
• Read Story

• January 10, 2012

• Horizon Discovery announces board member Simon Cook

•  
• Read Story

• November 21, 2011

• Collaboration with the National Cancer Institute and the National Human Genome Research Institute

•  
• Read Story

• November 07, 2011

• Strategic partnership with Promega to develop next-generation predictive human disease models

•  
• Read Story

• September 15, 2011

• Horizon Discovery Announces £11.3 Million ($18.6 Million) Fundraising

•  
• Read Story

• September 13, 2011

• Horizon Discovery Introduces Panel of Molecular Diagnostic Reference Standards

•  
• Read Story

• August 31, 2011

• Horizon Licenses New X-MAN Cell Lines from the Uni. of Minnesota relating to T-cell viral infections

•  
• Read Story

• August 09, 2011

• Horizon Discovery Expands Commercial Division with Senior Appointments & Increases its UK Premises

•  
• Read Story

• June 30, 2011

• Horizon Discovery Licenses 50 New X-MAN™ Cell Lines from Public University Corporation Yokohama City

•  
• Read Story

• June 14, 2011

• Horizon Successfully Completes Pilot Human Gene-Editing Program With Leading Pharma

•  
• Read Story

• April 19, 2011

• Horizon and Fox Chase Cancer Center announce a new Centre of Excellence in Mammalian Gene Editing

•  
• Read Story

• March 31, 2011

• Horizon receives $1.6M grant funding from EU FP7 program and joins the COLTHERES consortium

•  
• Read Story

• February 23, 2011

• Horizon Secures Exclusive License from Univ. of Pittsburgh to Panel of New Human Isogenic Cell Lines

•  
• Read Story

• February 01, 2011

• Horizon Secures Exclusive License to Homologous Recombination Inventions from Univ.of Minnesota

•  
• Read Story

• January 06, 2011

• Horizon and Univ. of Washington Announce Collaboration to Apply rAAV Gene Editing in iPS cells

•  
• Read Story

• December 14, 2010

• Horizon to Support 50 Centers of Excellence in Human Cellular Gene-Editing

•  
• Read Story

• December 09, 2010

• Horizon Secures License from Case Western to 35 Endogenously Tagged Human Isogenic Cell Lines

•  
• Read Story

• November 02, 2010

• Horizon and Mirna Therapeutics to Test Activities of Tumor Suppressor MicroRNAs in X-MAN Models

•  
• Read Story

• October 26, 2010

• Horizon’s X-MAN cell-models predict that a subset of KRAS mutated cancers respond to EGFR therapy

•  
• Read Story

• October 19, 2010

• Horizon and Cylene Pharmaceuticals Collaborate in Rational Selection of Patients for Clinical Trial

•  
• Read Story

• October 15, 2010

• Horizon Named Bioscience Company of the Future at the Cambridge Phenomenon Conference

•  
• Read Story

• October 05, 2010

• Horizon Acquires Hypoxium and Launches Horizon Discovery Services Ltd

•  
• Read Story

• September 28, 2010

• Horizon Closes £6.25M Series C Financing and Makes New Board Appointments

•  
• Read Story

• September 08, 2010

• Horizon and ICR to Collaborate on Genome-Wide Synthetic Lethality Screens

•  
• Read Story

• August 23, 2010

• Horizon and Sanger Institute Collaboration to Advance the Frontiers of Translational Genomics

•  
• Read Story

• August 08, 2010

• Horizon announces that it has been awarded €300,000 grant under EUFP7 program

•  
• Read Story

• May 25, 2010

• Horizon announce a series of new deals signed with leading Pharma & Biotech companies

•  
• Read Story

• April 12, 2010

• Horizon Partners with TGen Drug Development to offer an integrated personalized medicine service

•  
• Read Story

• March 16, 2010

• Horizon Secures license from the Univ. of Minnesota to new X-MAN Cell lines relating to DNA repair

•  
• Read Story

• February 26, 2010

• Horizon Receive Eurostars Award; $500,000 Grant to Model Non-inherited SNPs That May Drive Cancer

•  
• Read Story

• February 16, 2010

• Horizon Sign New Commercial Deals with Leading Pharma Companies

•  
• Read Story

• February 08, 2010

• Horizon Discovery Completes Materials Transfer Agreement with Sunesis Pharmaceuticals

•  
• Read Story

• February 02, 2010

• The Translational Genomics Research Inst. becomes center of excellence for GENESIS & X-MAN

•  
• Read Story

• December 21, 2009

• Horizon Discovery Sign Multi-Year Technology Access Agreement with Genentech Inc.

•  
• Read Story

• December 14, 2009

• Horizon Discovery and University of Washington Expand Gene-Targeting Licenses

•  
• Read Story

• November 25, 2009

• Horizon Signs Four-Year Collaboration with World-Leading Pharma to Develop X-MAN™ Cell-Lines

•  
• Read Story

• November 23, 2009

• Horizon Discovery to Expand and Establish New UK Headquarters at IQ Cambridge

•  
• Read Story

• November 17, 2009

• Expand Your Horizons and Join the iawards Technology Start-Up and Company of the Year 2009

•  
• Read Story

• November 16, 2009

• Horizon Discovery Named #1 UK Technology Start-Up and Company of the Year at iawards 2009

•  
• Read Story

• November 01, 2009

• News Horizon Discovery Signs Technology Evaluation Agreement with Array BioPharma

•  
• Read Story

• October 19, 2009

• Inside the X-MAN: Crack University of Liverpool Scientists to Mine Horizon’s Patient Relevent Models

•  
• Read Story

• October 17, 2009

• Horizon Makes Final Short-List for Innovation and Export Awards by ERBI

•  
• Read Story

• October 13, 2009

• Horizon Discovery Sign Cancer Metabolomics Service Agreement with Global Pharma GlaxoSmithKline

•  
• Read Story

• October 10, 2009

• Horizon Sign 2nd License Agreement with Ortho Biotech Oncology R&D, a division of Janssen NV.

•  
• Read Story

• September 15, 2009

• Horizon Discovery Announces World-Leading Translational Medicine & Gene-Targeting Experts on its SAB

•  
• Read Story

• August 24, 2009

• Horizon Discovery Sign Commercial Screening Agreement with Silicos NV.

•  
• Read Story

• August 11, 2009

• Newcastle University Scientists to Develop X-Ray Vision for Horizon Discovery’s X-MAN

•  
• Read Story

• August 06, 2009

• Horizon Sign Worldwide Exclusive License to New Inventions from Translational Medicine Researchers

•  
• Read Story

• August 04, 2009

• Horizon Sign License Agreement with Ortho Biotech Oncology R&D, division of Janssen Pharmaceutica NV

•  
• Read Story

• July 22, 2009

• Horizon and DxS to Lead the Way in Setting Standards for Companion Diagnostic Tests in Cancer

•  
• Read Story

• July 15, 2009

• Horizon Sign Commercial Screening Agreement with SuperGen Inc.

•  
• Read Story

• July 15, 2009

• Horizon Sign Commercial Agreement with British Columbia Cancer Agency

•  
• Read Story

• June 14, 2009

• Horizon Sign New Technology Licensing Deal with US Pharma Giant

•  
• Read Story

• June 12, 2009

• Horizon Appoint Dr Darrin M Disley as its New Executive Chairman

•  
• Read Story

• May 29, 2009

• Horizon Selected for Final of World Entrepreneurship Competition

•  
• Read Story

• April 05, 2009

• Horizon Discovery Co-founders Work to be Showcased as Breakthrough in Cancer Research at AACR 2009

•  
• Read Story

• April 02, 2009

• Horizon Discovery Sign Three-Year Collaboration with World-Leading Cancer Pharma Genentech

•  
• Read Story

• April 01, 2009

• Horizon Discovery and Biolog Inc Present Joint Data on X-MAN Cancer Metabolism

•  
• Read Story

• March 25, 2009

• Horizon Secures World-Wide Exclusive License from University of Maryland on new X-MAN Cell lines

•  
• Read Story

• January 07, 2009

• X-On-The-Beach: Horizon forms Commercial Alliance with GeneWorks in Australia & New Zealand

•  
• Read Story

• January 05, 2009

• Horizon Discovery Sign Agreement with Infinity Pharmaceuticals

•  
• Read Story

• December 17, 2008

• Horizon Sign Screening Agreement with Actelion Pharmaceuticals

•  
• Read Story

• December 15, 2008

• Horizon Signs Commercial Agreement with OSI Pharmaceuticals

•  
• Read Story

• December 03, 2008

• Horizon Sign Agreement With Novartis Institute of Biomedical Research

•  
• Read Story

• December 02, 2008

• Horizon Wins Medical Futures Innovation Awards in Cancer and Business

•  
• Read Story

• November 30, 2008

• Horizon Closes Screening Contract with Prolexys Pharmaceuticals

•  
• Read Story

• November 26, 2008

• Horizon Secures Exclusive Patent Position on Award-Winning GENESIS™ Platform

•  
• Read Story

• November 15, 2008

• Horizon Hiring new X-MEN Scientists for Cambridge and Torino Laboratories

•  
• Read Story

• October 17, 2008

• Horizon deploys GENESIS to engineer new X-MAN regiments for Millennium

•  
• Read Story

• October 01, 2008

• Horizon Sign Screening and License Agreements with Agios Pharmaceuticals

•  
• Read Story

• September 15, 2008

• Horizon Discovery Sign Agreement with Leading Cancer Pharma Millennium

•  
• Read Story

• September 13, 2008

• Horizon Discovery deploy new X-MAN regiments in the fight against cancer

•  
• Read Story

• August 26, 2008

• Horizon Discovery Make the Final Stages of the Medical Futures Innovation Awards

•  
• Read Story

• July 07, 2008

• Horizon Discovery: Hiring Now for Gene Engineering Lab, Torino, Italy

•  
• Read Story

• June 16, 2008

• Horizon to Find Drug Candidates for EU Stem Cell Consortium

•  
• Read Story

• June 01, 2008

• Horizon Discovery Appoints Dr Rob Howes as R&D Director

•  
• Read Story

• May 28, 2008

• Horizon Discovery & Cancer Research UK form Drug Discovery Venture

•  
• Read Story

• May 01, 2008

• Horizon Discovery signs drug profiling alliance with Hypoxium Ltd.

•  
• Read Story

• May 01, 2008

• Horizon Discovery opens new Gene Engineering laboratory in Torino, Italy

•  
• Read Story

• April 09, 2008

• Horizon Discovery sign drug profiling alliance with Caliper Life Science

•  
• Read Story

• April 07, 2008

• Horizon Discovery Ltd. secures further investment

•  
• Read Story

• January 05, 2008

• Horizon Discovery Ltd. signs a commercial agreement with AstraZeneca UK Ltd.

•  
• Read Story

• December 01, 2007

• Horizon Discovery Ltd. signs second commercial agreement with Genentech Inc.

•  
• Read Story

• October 16, 2007

• Horizon Discovery signs-up commercial partner Execute Technologies Inc.

•  
• Read Story

• August 19, 2007

• Horizon Discovery licenses cancer cell-lines to top US Cancer Pharma Genentech

•  
• Read Story

• July 12, 2007

• Horizon Discovery signs key agreements with Cambridge Enterprise & University of Washington

•  
• Read Story